1. Home
  2. INTT vs RVPH Comparison

INTT vs RVPH Comparison

Compare INTT & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • RVPH
  • Stock Information
  • Founded
  • INTT 1981
  • RVPH 2006
  • Country
  • INTT United States
  • RVPH United States
  • Employees
  • INTT N/A
  • RVPH N/A
  • Industry
  • INTT Semiconductors
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTT Technology
  • RVPH Health Care
  • Exchange
  • INTT Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • INTT 91.4M
  • RVPH 88.0M
  • IPO Year
  • INTT 1997
  • RVPH N/A
  • Fundamental
  • Price
  • INTT $8.94
  • RVPH $2.10
  • Analyst Decision
  • INTT Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • INTT 2
  • RVPH 5
  • Target Price
  • INTT $16.00
  • RVPH $11.40
  • AVG Volume (30 Days)
  • INTT 30.4K
  • RVPH 2.2M
  • Earning Date
  • INTT 03-26-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • INTT N/A
  • RVPH N/A
  • EPS Growth
  • INTT N/A
  • RVPH N/A
  • EPS
  • INTT 0.22
  • RVPH N/A
  • Revenue
  • INTT $121,971,000.00
  • RVPH N/A
  • Revenue This Year
  • INTT $7.31
  • RVPH N/A
  • Revenue Next Year
  • INTT $5.77
  • RVPH N/A
  • P/E Ratio
  • INTT $40.75
  • RVPH N/A
  • Revenue Growth
  • INTT N/A
  • RVPH N/A
  • 52 Week Low
  • INTT $6.28
  • RVPH $0.60
  • 52 Week High
  • INTT $14.35
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • INTT 53.13
  • RVPH 56.56
  • Support Level
  • INTT $8.70
  • RVPH $1.78
  • Resistance Level
  • INTT $9.30
  • RVPH $1.91
  • Average True Range (ATR)
  • INTT 0.39
  • RVPH 0.18
  • MACD
  • INTT -0.03
  • RVPH -0.00
  • Stochastic Oscillator
  • INTT 53.21
  • RVPH 86.00

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: